UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039442
Receipt number R000044970
Scientific Title Effects of the test food on intestinal microbiome.
Date of disclosure of the study information 2022/03/31
Last modified on 2020/02/10 09:26:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of the test food on intestinal microbiome.

Acronym

Effects of the test food on intestinal microbiome.

Scientific Title

Effects of the test food on intestinal microbiome.

Scientific Title:Acronym

Effects of the test food on intestinal microbiome.

Region

Japan


Condition

Condition

healthy humans

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of intake of the test food on intestinal microbiome in healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Intestinal microbiome

Key secondary outcomes

Oxidative stress in feces
Biochemical analysis (saliva)
Amylase
IL-6
Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of the water (530ml/day) for 8 weeks

Interventions/Control_2

Intake of the test food A (300ml) for 8 weeks

Interventions/Control_3

Intake of the test food B (20g) for 8 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Healthy men and women over 20 years old
(2) Who gave the informed consents in writing after receiving enough explanation of purpose and detail of the study, understanding the study well, and deciding to attend the study with their own will.

Key exclusion criteria

(1)Subjects who has treatment with warfarin.
(2)Subjects with the severe disease medical history.
(3)Subjects with the gastric hyperacidity.
(4)Subjects who are judged as inappropriate to be enrolled in this trials by chief investigator or sub investigators.
(5)When the subject wants to stop the measurement.
(6)When the examiner determines that measurement is difficult.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tadayuki
Middle name
Last name Iida

Organization

Prefectural University of Hiroshima.

Division name

Department of Physical Therapy, Faculty of Health and Welfare

Zip code

723-0053

Address

1-1 Gakuen-cho, Mihara City, Hiroshima Pref. 723-0053, Japan

TEL

0848-60-1196

Email

iida@pu-hiroshima.ac.jp


Public contact

Name of contact person

1st name Tadayuki
Middle name
Last name Iida

Organization

Prefectural University of Hiroshima.

Division name

Department of Physical Therapy, Faculty of Health and Welfare

Zip code

723-0053

Address

1-1 Gakuen-cho, Mihara City, Hiroshima Pref. 723-0053, Japan

TEL

0848-60-1196

Homepage URL


Email

iida@pu-hiroshima.ac.jp


Sponsor or person

Institute

Prefectural University of Hiroshima.

Institute

Department

Personal name



Funding Source

Organization

SAPPORO HOLDINGS LTD.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

SAPPORO HOLDINGS LTD.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Prefectural University of Hiroshima.

Address

1-1 Gakuen-cho, Mihara City, Hiroshima Pref. 723-0053, Japan

Tel

0848-60-1120

Email

yosikawa@pu-hiroshima.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 05 Month 08 Day

Date of IRB

2019 Year 03 Month 13 Day

Anticipated trial start date

2019 Year 09 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 06 Month 30 Day

Date trial data considered complete

2020 Year 10 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 02 Month 10 Day

Last modified on

2020 Year 02 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044970